Skip to main content
Log in

Chairman's introduction Determinants of inflammation test selection:In vitro orin vivo?

  • Experimental Models of Inflammation
  • Published:
Agents and Actions Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. M.J.H. Smith andP.D. Dawkins,Salicylate and enzymes, J. Pharm. Pharmac.23, 729–744 (1971).

    Google Scholar 

  2. R.J. Flower andJ.R. Vane,Inhibition of prostaglandin biosynthesis, Biochem. Pharmac.23, 1439–1450 (1974).

    Article  Google Scholar 

  3. T.Y. Shen, S.-B. Hwang, M.N. Chang, T.W. Doebber, M.-H.T. Lam, M.S. Wu, X. Wang, G.Q. Han andR.Z. Li,Characterization of a plateletactivating factor receptor antagonist isolated from haifenteng (Piper futokadsura):Specific inhibition of in vitroand in vivoplatelet-activating factor-induced effects, Proc. natl. Acad. Sci. USA,82, 672–676.

  4. S. Leyck, E. Etschenberg, U. Hadding andJ. Winkelmann,A new model of acute inflammation: Cobra venom factor induced paw oedema, Agents and Actions13, 437–438 (1983).

    Google Scholar 

  5. M.J. Parnham, H. Borbe, P. Kuhl andS. Leyck,Ebselen and other lipoxygenase inhibitors: comparative inhibition of arachidonate oxygenation and cobra venom factor oedema, Int. J. Immunopharmac.,7, 394.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parnham, M.J. Chairman's introduction Determinants of inflammation test selection:In vitro orin vivo?. Agents and Actions 17, 327–328 (1986). https://doi.org/10.1007/BF01982637

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01982637

Keywords

Navigation